FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to ophthalmology, and aims at treating and preventing high intraocular pressure. Drug for treating and preventing high intraocular pressure includes one active substance and an additive. Active substance used is glycerol trinitrate, and the additive used is 1 % hyaluronic acid. Components are used in claimed amounts.
EFFECT: use of the invention enables higher clinical effectiveness and prevention of high intraocular pressure.
1 cl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
NEW THERAPEUTIC APPROACH TO INTRAOCULAR PRESSURE INCREASE | 2007 |
|
RU2458703C2 |
USE OF SUBSTANCES FOR TREATING VISION LOSS IN INDIVIDUALS SUFFERING GLAUCOMA AND OTHER DEGENERATIVE OCULAR DISEASES | 2008 |
|
RU2481120C2 |
METHOD FOR PRODUCTION OF EGG YOLK WITH HIGH CONTENT OF AF-16 | 2016 |
|
RU2723097C1 |
COMBINED CHONDROPROTECTIVE PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2381029C1 |
LIPID RAFT MODULATION | 2007 |
|
RU2457853C2 |
NEW APPROACH TO TREATMENT OF COMPARTMENT - SYNDROME | 2007 |
|
RU2465914C2 |
NEW NPR-B AGONISTS | 2010 |
|
RU2636738C2 |
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING EYE DISEASES, CONTAINING, AS ACTIVE INGREDIENT, FUSION PROTEIN IN WHICH TISSUE-PENETRATING PEPTIDE AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR PREPARATION ARE FUSED | 2016 |
|
RU2712623C2 |
COMPLEMENT-BINDING APTAMERS AND C5 AGENTS APPLICABLE FOR TREATING OCULAR DISORDERS | 2007 |
|
RU2477137C2 |
PHARMACEUTICAL COMPOSITION IN FORM OF GEL-LIKE OPHTHALMIC DROPS FOR TREATING GLAUCOMA | 2015 |
|
RU2576778C1 |
Authors
Dates
2019-07-05—Published
2018-09-06—Filed